173RD AIRBORNE, N Co. 75th Inf. Long Range Reconnaissance Patrol .
Vietnam 68-69, you can read about my unit and myself in a book written by my buddy Bill Shanahan, " Stealth Patrol..." I was RTO for Team G.
Look at SNTS, on Nov 7 it closed at about $22+, at 4:01PM after market close, the Buy Out news was released and when the stock opened on Nov 8, it opened at $32. INSTANT DEATH, with virtually no chance of dropping back down. Shorts can not Cover and can not push it back down. ....be still my heart. I LOVE IT.
"The Lancet. In the -020 Study, pimavanserin demonstrated significant and clinically meaningful benefits and was safe and well tolerated in patients with PDP. Pimavanserin significantly reduced psychosis and maintained motor control in patients with PDP. Significant benefits were also observed in exploratory measures of nighttime sleep, daytime wakefulness and caregiver burden. "
Did Cramer send you an alert to Buy ACAD at $7? or even at $12...NO. Did he tell you to SELL SELL SELL at $29...NO. He is "AFTER THE FACT". BASICALLY HE IS AN OPPORTUNIST. If you are going to blame someone, blame yourself...If you got tapped out and made a profit, pat yourself on the back. Now move on.
The MM will be shaking the tree this AM. if you use a sell stop you will get your shares snapped up CHEAP. I don't like Sell Stops at this time. I prefer to have a "mental sell stop". eg, If the price crosses a level I am uncomfortable with I sell. eg, (breaking major support levels) . My experience is MM's are smart and have control over my shares if I give him/her the chance.
Going to cost them Big Bucks to pay off the 22 deaths and injured. Probably close to a Billion, and that is not counting the investor Class Action....OUCH !
I wouldn't touch that company,,,nothing but a bunch of Phase 1's and pre clinical studies...and its still $15...WOW ITS STILL OVER PRICED. Geez anyone who buys that stock is taking a HUGE risk. SELL IT and MOVE ON.
Thanks for you and family for serving and putting your life on the line for the American people.
Even with a market cap of over $2B, we feel Acadia could fetch as much as $6B if the FDA approves pimavanserin, which could happen in the next 6 to 8 months.
Agree, but don't be surprised to get low balled on the first bid. Say $35/share. Then either another bid or another company joining in. Eventually it will end up about $50/share. After all there is JNJ, MRK , PFE, ALL CASH RICH etc that can jump in. When you see the word " HALTED ! " you will know.